Skip to content

The study of the endoscopic oropharyngeal airway applyied to upper gastrointestinal endoscopy under anesthesia: a randomized controlled trial.

Efficacy and safety of the endoscopic oropharyngeal airway applyied to upper gastrointestinal endoscopy under anesthesia

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000031998
Enrollment
Unknown
Registered
2020-04-17
Start date
2020-04-05
Completion date
Unknown
Last updated
2020-04-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

upper gastrointestinal endoscopy under anesthesia

Interventions

Group A:Oral Pad
Group B:Endoscopic oropharyngeal airway

Sponsors

Department of Anesthesiology, the First Affiliated Hospital of USTC; Division of Life Sciences and Medicine, University of Science and Technology of China,
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: Patients receiving upper gastrointestinal endoscopy under monitored anesthesia in The First Affiliated Hospital of USTC.

Exclusion criteria

Exclusion criteria: ASA III- IV; Patients with coagulopathy and tendency of nose bleeding; Patients with any diagnosed cardiac diseases (e.g. cardiac failure, angina, MI, cardiac arrhythmia. etc.); Patients with any diagnosed pulmonary disease (e.g. asthma, COPD, pulmonary embolism, pulmonary edema etc.); Pregnant patients; Patients with liver failure; Patients with kidney failure;Patients with oropharynx malformation;Patients allergic to Dyclonine, propofol, or sufentanil.

Design outcomes

Primary

MeasureTime frame
lowest SpO2;

Secondary

MeasureTime frame
times needed to use mask ventilation;blood pressure;heart rate;Endoscope insertion time;

Countries

China

Contacts

Public ContactZhang Wei

Department of Anesthesiology, the First Affiliated Hospital of USTC; Division of Life Sciences and Medicine, University of Science and Technology of China

zw97079@163.com+86 13856042616

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 19, 2026